Clinical Trial Update: Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial [Phase 3]

View source ↗

Summary

A Phase 3 treatment extension study for patients who previously participated and benefited from iniparib; completed trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Iniparib (iparib)

Snippet

Sponsor: Sanofi | Conditions: Solid Tumors | Phase 3 | Status: COMPLETED